Literature DB >> 26893054

Preparation and characterization of acetylated starch nanoparticles as drug carrier: Ciprofloxacin as a model.

Seyed Heydar Mahmoudi Najafi1, Maryam Baghaie2, Alireza Ashori2.   

Abstract

The objective of this study was to characterize in-vitro the potential of acetylated corn starch (ACS) particles as a matrix for the delivery of ciprofloxacin (CFx). ACS was successfully synthesized and optimized by the reaction of native corn starch using acetic anhydride and acetic acid with low and high degrees of substitution (DS). The nanoprecipitation method was applied for the formation of the ACS-based nanoparticles, by the dropwise addition of water to acetone solution of ACS under stirring. The effects of acetylation and nanoprecipitation on the morphology and granular structure of ACS samples were examined by the FT-IR, XRD, DSL and SEM techniques. The efficiency of CFx loading was also evaluated via encapsulation efficiency (EE) in ACS nanoparticles. The average degree of acetyl substitution per glucose residue of corn starch was 0.33, 2.00, and 2.66. The nanoparticles size of the ACS and ACS-loaded with CFx were measured and analyzed relative to the solvent:non-solvent ratio. Based on the results, ACS nanoparticles with DS of 2.00 and water:acetone of 3:1 had 312nm diameter. Increasing DS in starch acetate led to increase in the EE from 67.7 to 89.1% and with increasing ratio of water/acetone from 1:1 to 3:1, the EE raised from 48.5 to 89.1%. X-ray diffraction indicated that A-type pattern of native starch was completely transformed into the V-type pattern of acetylated starch. The scanning electron microscopy showed that the different sizes of pores formed on the acetylated starch granules were utterly converted into the uniform-sized spherical nanoparticles after the nanoprecipitation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylated corn starch; Ciprofloxacin; Drug carrier; Encapsulation; Nanoprecipitation

Mesh:

Substances:

Year:  2016        PMID: 26893054     DOI: 10.1016/j.ijbiomac.2016.02.030

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Optimization and characterization of high pressure homogenization produced chemically modified starch nanoparticles.

Authors:  Yongbo Ding; Jianquan Kan
Journal:  J Food Sci Technol       Date:  2017-10-26       Impact factor: 2.701

2.  Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.

Authors:  Bassam Felipe Mogharbel; Marco André Cardoso; Ana Carolina Irioda; Priscila Elias Ferreira Stricker; Robson Camilotti Slompo; Julia Maurer Appel; Nathalia Barth de Oliveira; Maiara Carolina Perussolo; Claudia Sayuri Saçaki; Nadia Nascimento da Rosa; Dilcele Silva Moreira Dziedzic; Christophe Travelet; Sami Halila; Redouane Borsali; Katherine Athayde Teixeira de Carvalho
Journal:  Molecules       Date:  2022-04-28       Impact factor: 4.927

3.  Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.

Authors:  Ahmed R Gardouh; Ahmed S G Srag El-Din; Mohamed S H Salem; Yasser Moustafa; Shadeed Gad
Journal:  Drug Des Devel Ther       Date:  2021-07-16       Impact factor: 4.162

4.  Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment.

Authors:  Esma Alp; Fehmi Damkaci; Eylem Guven; Martin Tenniswood
Journal:  Int J Nanomedicine       Date:  2019-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.